Literature DB >> 22086613

Unilateral basal-ganglia involvement likely due to valproate-induced hyperammonemic encephalopathy.

Swarnali Joardar1, Shubhadeep Das, Rita Chatterjee, Gautam Guha, M A Hasmi.   

Abstract

A male child suffering from generalized tonic clonic epilepsy, on treatment with valproate, developed fulminant hepatic failure, hyperammonemia and encephalopathy due to drug toxicity. The most extraordinary feature was his MRI (FLAIR image) of brain which showed unilateral hyperintensities in right putamen and caudate nucleus. The patient recovered on withdrawal of valproate with mild residual left sided athetotic movements during remission. Repeat investigation confirmed an improved MRI imaging and normalised blood ammonia levels. The case report is unique because of unilateral involvement of basal ganglia due to valproate-induced encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086613     DOI: 10.1007/s10072-011-0852-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  Valproate-induced hyperammonemic encephalopathy.

Authors:  Nadir Yehya; Candace Tom Saldarini; Michelle E Koski; Pablo Davanzo
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2004-08       Impact factor: 8.829

2.  Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure.

Authors:  W J Triggs; R L Gilmore; D S Millington; J Cibula; T S Bunch; E Harman
Journal:  Int J Clin Pharmacol Ther       Date:  1997-09       Impact factor: 1.366

Review 3.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

4.  Pure agraphia and unilateral optic ataxia associated with a left superior parietal lobule lesion.

Authors:  S H Auerbach; M P Alexander
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

Review 5.  The value of morphological neuroimaging after acute exposure to toxic substances.

Authors:  Philippe Hantson; Thierry Duprez
Journal:  Toxicol Rev       Date:  2006

Review 6.  Carnitine in the treatment of valproic acid-induced toxicity.

Authors:  Philippe E R Lheureux; Philippe Hantson
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

7.  Effect of L-carnitine supplementation on acute valproate intoxication.

Authors:  K Murakami; T Sugimoto; M Woo; N Nishida; H Muro
Journal:  Epilepsia       Date:  1996-07       Impact factor: 5.864

8.  Stuporous episodes during treatment with sodium valproate: report of seven cases.

Authors:  C Marescaux; J M Warter; G Micheletti; L Rumbach; G Coquillat; D Kurtz
Journal:  Epilepsia       Date:  1982-06       Impact factor: 5.864

9.  Valproate-induced encephalopathy: assessment with MR imaging and 1H MR spectroscopy.

Authors:  Sargon Ziyeh; Thorsten Thiel; Joachim Spreer; Joachim Klisch; Martin Schumacher
Journal:  Epilepsia       Date:  2002-09       Impact factor: 5.864

Review 10.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.